TIDMNMC
RNS Number : 8388A
Emirates NBD Capital
24 January 2020
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN
PART, DIRECTLY OR INDIRECTLY, TO US PERSONS, OR IN OR INTO THE
UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA OR SOUTH AFRICA
OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, DISTRIBUTION
OR RELEASE WOULD BE UNLAWFUL.
THIS ANNOUNCEMENT IS NOT A PROSPECTUS AND NOT AN OFFER OF
SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING THE UNITED
STATES, CANADA, JAPAN, AUSTRALIA OR SOUTH AFRICA.
PRESS RELEASE
24 January 2020
Announcement in relation to the results of an accelerated
bookbuild
Further to the announcement on 23 January 2020, Emirates NBD
Bank (PJSC) ("ENBD") announces the completion of the accelerated
bookbuild offering (the "Placing") which has resulted in the sale
of 2,163,850 existing ordinary shares (the "Shares") in NMC Health
PLC (the "Company") (representing c.1.04% of the issued share
capital of the Company) at a price of GBP12.50 per Share, raising
gross proceeds of approximately GBP 27,048,125 million.
The sale of the Shares was made pursuant to the repayment of a
related loan entered into by Infinite Investment LLC (as borrower)
with ENBD (as lender).
The bookrunner for the Placing was Emirates NBD Capital Ltd
("ENBD Capital"). Settlement is expected to occur on 28 January
2020.
Enquiries:
ENBD Capital:
Alan Twinn
Alant@emiratesnbd.com
Tel +971 (0) 4 303 2818
Mob +971 (0) 50 901 1674
Prasad Chari
PrasadCH@emiratesNBD.com
Tel +971 (0) 4 303 2897
Mob +971 (0) 50 628 9002
IMPORTANT NOTICE
This announcement is for information purposes only and shall not
constitute or form part of an offer to buy, sell, issue, acquire or
subscribe for, or the solicitation of an offer to buy, sell, issue,
acquire or subscribe for any securities (including, without
limitation, the Shares), nor shall there be any sale of securities
(including, without limitation, the Shares) in any jurisdiction in
which such offer, solicitation or sale would be unlawful. Any
failure to comply with these restrictions may constitute a
violation of the securities laws of such jurisdictions.
The distribution of this announcement may be restricted by law
in certain jurisdictions and persons into whose possession any
document or other information referred to herein comes should
inform themselves about and observe any such restriction. The offer
and sale of the Shares referred to herein has not been and will not
be registered under the US Securities Act of 1933 (the "Securities
Act") or under the applicable securities laws of Australia, Canada,
Japan or South Africa. Absent registration under the Securities Act
or an exemption from the registration requirements of the
Securities Act, the Shares referred to herein may not be offered or
sold in the United States, and subject to certain exceptions, the
Shares referred to herein may not be offered or sold in Australia,
Canada, Japan or South Africa. There will be no public offer of the
Shares in the United States, Australia, Canada, Japan, South Africa
or any other jurisdiction.
This announcement is only directed at, and being distributed to
persons outside the United States who are: (i) in any member state
of the European Economic Area (other than the United Kingdom),
qualified investors within the meaning of Article 2 of the
Prospectus Regulation (Regulation (EU) 2017/1129 of 14 June 2017)
("Qualified Investors"); or (ii) Qualified Investors in the United
Kingdom who (A) have professional experience in matters relating to
investments (i.e. investment professionals within the meaning of
Article 19(5) of the Financial Services and Markets Act 2000
(Financial Promotion) Order 2005, as amended (the "Order")), are
high net worth entities falling within the meaning of Article
49(2)(a) to (d) of the Order or are persons to whom it can
otherwise be lawfully distributed (together, such persons referred
to in this sub-paragraph (ii) being "relevant persons"). This
announcement must not be acted on or relied on (a) in the United
Kingdom by persons who are not relevant persons, or (b) in any
member state of the European Economic Area (other than the United
Kingdom), by persons who are not Qualified Investors. Any
investment or investment activity referred to in this announcement
is only available to, and will only be engaged in with, (1)
relevant persons, in the United Kingdom and (2) Qualified Investors
and other persons who are permitted to purchase securities pursuant
to an exemption from the Prospectus Regulation and other applicable
legislation, in any member state of the European Economic Area
(other than the United Kingdom).
No prospectus or offering document has been or will be prepared
in connection with the Placing. Any investment decision to buy
securities in the Placing must be made solely on the basis of
publicly available information. Such information is not the
responsibility of, and has not been independently verified by, any
of ENBD or ENBD Capital or any of their respective affiliates.
ENBD Capital Ltd is regulated by the Dubai Financial Services
Authority and ENBD Capital PSC is regulated by the Central Bank of
the UAE. ENBD Capital is acting exclusively for ENBD and no other
person in connection with the Placing. ENBD Capital and ENBD will
not regard any other person as their client in relation to the
Placing and will not be responsible to any other person for
providing the protections afforded to their clients, nor for
providing advice in relation to the contents of this announcement
or any transaction, arrangement or other matter referred to herein
(including, without limitation, the Placing).
In connection with any offering of the Shares, ENBD Capital and
any of its affiliates, acting as an investor for its own account,
may take up as a proprietary position any Shares and, in that
capacity, may retain, purchase or sell for its own accounts such
Shares. In addition, any of such persons may enter into financing
arrangements and swaps with investors in connection with which it
may from time to time acquire, hold or dispose of Shares. It does
not intend to disclose the extent of any such investment or
transactions, otherwise than in accordance with any legal or
regulatory obligation to do so.
None of ENBD or ENBD Capital, nor any of their respective
directors, officers, employees, advisers or agents accepts any
responsibility or liability whatsoever for, or makes any
representation or warranty, express or implied, as to, the truth,
accuracy or completeness of the information in this announcement
(or whether any information has been omitted from the announcement)
or any other information relating to the Company or any of their
subsidiaries or associated companies, whether written, oral or in a
visual or electronic form, and howsoever transmitted or made
available or for any loss howsoever arising from any use of this
announcement or its contents or otherwise arising in connection
therewith.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
FURBIMATMTATMMM
(END) Dow Jones Newswires
January 24, 2020 02:00 ET (07:00 GMT)
Grafico Azioni Nmc Health (LSE:NMC)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Nmc Health (LSE:NMC)
Storico
Da Apr 2023 a Apr 2024